GlaxoSmithKline has become the latest pharmaceuticals company to be accused of paying bribes to win business in China. In the past year, Eli Lilly and Pfizer have reached settlements with US authorities over similar allegations concerning their conduct in China.
葛兰素史克（GlaxoSmithKline，简称GSK）成为最新一家被控靠行贿在manbetx3.0 市场赢取业务的制药公司。去年，礼来(Eli Lilly)和辉瑞(Pfizer)已就关于其在manbetx3.0 行为的类似指控，与美国监管当局达成了和解。
您已阅读12%（372字），剩余88%（2828字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。